References
- Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210
- Lanteri-Minet M, Valade D, Geraud G, et al. Migraine and probable migraine – results of Framig 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 2005;25:1146-58
- The international classification of headache disorders, 2nd edn. Cephalalgia 2004;24(Suppl. 1):9-160
- Lanteri-Minet M. What do patients want from their acute migraine therapy?. Eur Neurol 2005;53(Suppl. 1):3-9
- Brandes JL. Global trends in migraine care: results from the maze survey. CNS Drugs 2002;16(Suppl. 1):13-18
- Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of Framig 3, a French nationwide population-based survey. Headache 2006;46:715-25
- Lucas C, Chaffaut C, Artaz MA, et al. Framig 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005;25:267-79
- Lanteri-Minet M, Alchaar H, Besson G, et al. The migraine disability assessment (MIDAS) questionnaire: reliability of the French version. Cephalalgia 2003;23:750
- Stewart WF, Lipton RB, Kolodner K, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19:107-14 discussion 174
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 1988;8(Suppl. 7):1-96
- Lépine JP, L’échelle HAD. L’évaluation Clinique Standardisée en Psychiatrie. Paris: Editions Médicales Pierre Fabre, 1996
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
- Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20:554-60
- Nett RB, Tiseo PJ, Almas M, et al. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. Int J Clin Pract 2007;61:1677-85
- Leinisch-Dahlke E, Akova-Ozturk E, Bertheau U, et al. Patient preference in clinical trials for headache medication: the patient’s view. Cephalalgia 2004;24:347-55
- Malik SN, Hopkins M, Young WB, et al. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache 2006;46:773-80
- Geraud G, Lanteri-Minet M, Lucas C, et al. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004;26:1305-18
- Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-ht(1b/1d) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668-75
- Pascual J, Mateos V, Roig C, et al. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 2007;47:1152-68
- Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62